XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation
LOS ALTOS, California, Aug. 31, 2026 (GLOBE NEWSWIRE) — Open-label, dose-escalation study using cardiac rhythm data from implantable and wearable AF monitors allows the treating physician to titrate the dose of budiodarone monthly.
First European patient dosed in CLN-209 (HARBOR-AF) Study is the first to titrate an antiarrhythmic drug against continuously monitored AF burden (AFB) […]
Health, science and environment breakthroughs
- Effortless when clear, tiring when it's not - the quiet math of vision Times Of India —
- This one tiny appliance can boost your brainpower in 30 days, reveals study Times Of India —
- ‘You can’t protect what you don’t know:’ Interview with marine scientist Loyiso Dunga Mongabay —
- Why the image of 'clean and green' is no longer enough for Australian agriculture exports Phys.org —
- Two Canadian builders turned 612,000 recycled plastic bottles into a 2,000-sq-ft home; its panels were tested to withstand sustained winds of 326 mph, twice Category 5 hurricane strength Times Of India —